What happened with Phase-3 Trial Demonstrates Success for Personalised Cancer Vaccine in Melanoma?

Question

Accepted Answer

Shows significant progress in preventing skin cancer recurrence using mRNA-based tailored vaccines in global trials. A high-profile Phase-3 clinical trial of a novel personalized cancer vaccine demonstrated encouraging results in treating patients with high-risk melanoma, a severe form of skin cancer. The trial resu

21 August 2026 Current Affairs

Phase-3 Trial Demonstrates Success for Personalised Cancer Vaccine in Melanoma